Integrated bio-affinity nano-platform into a microfluidic immunosensor based on monoclonal bispecific trifunctional antibodies for the electrochemical determination of epithelial cancer biomarker
A novel microfluidic immunosensor for EpCAM quantification was developed. This is based on the use of anti-EpCAM monoclonal recombinant antibodies. The electrochemical method presented a good analytical performance. This device could be used in diagnosis and prognosis of epithelial cancer.